GB 2763-2016 THIS REPORT CONTAINS ASSESSMENTS OF COMMODITY AND TRADE ISSUES MADE BY USDA STAFF AND NOT NECESSARILY STATEMENTS OF OFFICIAL U.S. GOVERNMENT POLICY Voluntary - Public Date: 3/31/2017 GAIN Report Number: CH17016 China - Peoples Republic of Post: Beijing China Releases New Maximum Residue Limits for Pesticides in Food Report Categories: FAIRS Subject Report Approved By: Lisa Anderson Prepared By: FAS Staff Report Highlights: On December 18, 2016, the Chinese National Health and Family Planning Commission, Ministry of Agriculture, China Food and Drug Administration released the National Food Safety Standard - Maximum Residue Limits for Pesticides in Foods (GB 2763-2016). The standard will replace the current MRL Standard (GB 2763-2014) and will be implemented on June 18, 2017. This report provides an unofficial translation of the standard. Editors’ Note: The asterisk appearing in the MRL column means that the limit is a temporary MRL. A temporary MRL is usually set under the following four conditions: 1. The dietary risk assessment data is incomplete; 2. The Acceptable Daily Intake (ADI) is temporary (ADI is used as the basis for MRL setting); 3. There is no surveillance or analysis method for the MRL that complies with the standard requirements; 4. In emergency situations, the pesticide is approved to be used on un-registered crops. I GB 2763-2016 General Information: BEGIN TRANSLATION ICS 65.100 G 25 GB National Standard of the People’s Republic of China GB 2763—2016 Replacing GB 2763 - 2014 National food safety standard Maximum Residue Limits for Pesticides in Food General Information: National Health and Family Planning Commission Issued by: Ministry of Agriculture China Food and Drug Administration Issued on: 2016-12-18 Implementation:2017-06-18 II GB 2763-2016 Table of Content Preface ................................................................................................................................................................ 13 1 Scope .............................................................................................................................................................. 15 2 Normative reference ....................................................................................................................................... 15 3 Terms and definitions ..................................................................................................................................... 22 3.1 Residue definition ....................................................................................................................................... 22 3.2 Maximum residue limit (MRL) ................................................................................................................... 22 3.3 Extraneous maximum residue limit (EMRL) .............................................................................................. 22 3.4 Acceptable daily intake (ADI) .................................................................................................................... 22 4 Technical requirements .................................................................................................................................. 22 4.1 2,4-D and 2,4-D Na ..................................................................................................................................... 22 4.2 2,4-D butylate ............................................................................................................................................... 23 4.3 2,4-D-ethylhexyl .......................................................................................................................................... 23 4.4 MCPA (sodium) ........................................................................................................................................... 23 4.5 MCPA-isooctyl ............................................................................................................................................ 24 4.6 Abamectin .................................................................................................................................................... 24 4.7 Chlormequat ................................................................................................................................................. 25 4.8 Picloram ....................................................................................................................................................... 25 4.9 Ethametsulfuron ........................................................................................................................................... 26 4.10 Diethyl aminoethyl hexanoate .................................................................................................................... 26 4.11 Paraquat ...................................................................................................................................................... 26 4.12 Chlorothalonil ............................................................................................................................................ 27 4.13 Azinphos-methyl ........................................................................................................................................ 28 4.14 Fenthion ..................................................................................................................................................... 28 4.15 Fenbutatin oxide ......................................................................................................................................... 29 4.16 Dichlofluanid.............................................................................................................................................. 30 4.17 Tribenuron-methyl ..................................................................................................................................... 30 4.18 Benomyl ..................................................................................................................................................... 30 4.19 Fenothiocarb ............................................................................................................................................... 31 4.20 Benzoximate ............................................................................................................................................... 31 4.21 Difenoconazole .......................................................................................................................................... 31 4.22 Saflufenacil ................................................................................................................................................ 32 4.23 Metamitron ................................................................................................................................................. 32 4.24 Mefenacet ................................................................................................................................................... 33 4.25 Benalaxyl ................................................................................................................................................... 33 4.26 Zoxamide ................................................................................................................................................... 33 4.27 Fenamiphos ................................................................................................................................................ 34 4.28 Fenpropidin ................................................................................................................................................ 34 4.29 Pyriproxyfen ............................................................................................................................................... 35 4.30 Pyraflufen-ethyl .......................................................................................................................................... 35 4.31 Imidacloprid ............................................................................................................................................... 35 III GB 2763-2016 4.32 Fluazifop and fluazifop-P-butyl ................................................................................................................. 36 4.33 Diflufenican................................................................................................................................................ 36 4.34 Pyrazosulfuron-ethyl .................................................................................................................................. 36 4.35 Pymetrozine................................................................................................................................................ 37 4.36 Metazachlor ................................................................................................................................................ 37 4.37 Pyraclostrobin ............................................................................................................................................ 37 4.38 Bensulfuron-methyl .................................................................................................................................... 38 4.39 Pretilachlor ................................................................................................................................................